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ABSTRACT
The American University in Cairo
ATP SYNTHASE: INVESTIGATING ITS IN VIVO ROTATION AND TESTING THE
INHIBITORY EFFECTS OF DIARYLQUINOLINES
By Sarah Hassan Radwan
Under the supervision of Dr. Hassan M.E. Azzazy and Dr. Dirk Bald
The rotation of the central subunits of ATP synthase relative to the surrounding parts has been
observed by several techniques, however, most previous studies were carried out using the
purified protein immobilized on glass slides or incorporated into liposomes. In this project, we
labeled the enzyme using site-specific fluorescent tags, which would allow the observation of the
HQ]\PH¶Vrotation in vivo. This system might also reveal if ATP synthase displays a favored
resting position. To carry out these experiments, the a-subunit of the enzyme was fused to cyan
fluorescent protein (CFP) ZKLOHWKHȖ-subunit was labeled with fluorescein arsenical hairpin
binder (FlAsH), a small fluorescent probe. Fluorescence resonance energy transfer (FRET)
experiments were carried out using inverted membrane vesicles and whole cells of Escherichia
coli. Labeling with the site-specific fluorophores was successful and the labeled enzyme was
functional. Moreover, FRET was observed between the two fluorescent labels in inverted
membrane vesicles. The FRET efficiency was dependent on the nucleotides present, which may
be due to a rotation-dependent FRET efficiency, but may also be explained by direct interaction
between ATP and one of the used fluorophores. ATP synthase also represents a promising drug
target for the diarylquinolines (DARQs) which can efficiently kill drug-sensitive and drugresistant Mycobacterium tuberculosis. However, it is not known how DARQs interfere with the
catalytic cycle of ATP synthase, a question which may be addressed using single-molecule
detection techniques. E. coli, the most used bacterial model system, is resistant to DARQs at
whole cell level. However, it is not known if this resistance stems from the lack of binding of
DARQs to ATP synthase or from the possibility that ATP synthesis may not be essential for E.
coli compared to M. tuberculosis. We tested if ATP synthesis in E. coli is susceptible to two
different DARQs. Neither of the two DARQs showed high affinity for E. coli ATP synthase.
However, one of them inhibited ATP synthesis at elevated concentrations (50% inhibitory
concentration [IC50] ~ 25 µM). These results will allow the use of single-molecule FRET
experiments in E. coli to further investigate the mechanism of DARQ action.
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1. LITERATURE REVIEW
ATP synthase is one of the most important enzymes present in all living organisms (bacteria,
chloroplasts, and mitochondria). It synthesizes ATP, the energy currency of living cells, from
ADP and inorganic phosphate (Pi). It is a large protein complex (~500 kDa) consisting of two
parts: a hydrophobic transmembrane portion, Fo, which is responsible for proton translocation
across the membrane and a water-soluble portion, F1, containing the catalytic nucleotide-binding
sites and responsible for ATP synthesis/hydrolysis (Yoshida et al. 2001; von Ballmoos et al.
2009). ATP synthase uses a rotational mechanism to couple proton translocation with ATP
synthesis making it WKHZRUOG¶VVPDOOHVWPRWRU (Boyer 1997). The enzyme synthesizes ATP
using the energy of the proton motive force. This force drives the rotation of Fo which in turn
causes the rotation of F1 leading to conformational changes in the catalytic sites of F1 necessary
for ATP synthesis (Boyer 1997; von Ballmoos et al. 2009). The simplest form of the enzyme is
the bacterial form, which has the following subunit FRPSRVLWLRQĮ3ȕ3ȖįİIRr the F1 portion and
a1b2c10-15 for the Fo portion (Figure 1). In Escherichia coli, the c-ring consists of 10 subunits
whereas in other organisms it consists of 10 to 15 subunits (von Ballmoos et al. 2009). The
enzyme could also be divided into a rotor (F1 Ȗİ- Fo c10-15) and a stator (F1 Į3ȕ3į- Fo ab2)
(Yoshida et al. 2001). The side stalk, which is made of the į- and b2-subunits, prevents the stator
from being dragged by the rotor (Yoshida et al. 2001).
Several experiments were carried out to observe the rotation of the F1 and Fo motors
using different rotation markers. 7KHURWDWLRQRIWKHȖ-subunit labeled with a fluorescent actin
filament was observed during ATP hydrolysis using the F1 part immobilized on nickelnitrilotriacetic acid (Ni-NTA)-coated glass slides (Noji et al. 1997; Yasuda et al. 1998; Hisabori
et al. 1999; Noji et al. 1999; Omote et al. 1999). It was shown that ATP hydrolysis drove a 360°
unidirectional rotation of the actin filament in three 120° steps. 7KHȖ-subunit has also been
labeled with smaller markers such as single fluorophores (Adachi et al. 2000) and 40-nm
colloidal gold nanoparticles, which allowed the rapid rotation of F1 and the resolution of the
rotational substeps RIWKHȖ-subunit (Yasuda et al. 2001). It was found that the 120° rotational
step consists of 90° and 30° substeps which were shown in later studies to be 80° and 40°
substeps (Shimabukuro et al. 2003; Nishizaka et al. 2004; Adachi et al. 2007). Furthermore,
manipulation of the rotation of the F1 motor via redox switching or simultaneous optical and
chemical stimuli has led to further understanding of how the enzyme can be regulated (Bald et al.
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2001; Ristic et al. 2009). In these studies, the Į3ȕ3ȖFRPSOH[RI)1 was immobilized on a glass
VOLGHDQGWKHȖ-subunit was labeled with single or duplex polystyrene beads and rotation was
observed using a microscope. Single-molecule fluorescence resonance energy transfer (FRET)
experiments have also been carried out to observe the stepwise rotation of WKHȖ-subunit relative
to the b-subunit using fully active FoF1-ATP synthase from E. coli. The individual doublelabeled enzymes were incorporated into liposomes and rotation was observed during ATP
synthesis and hydrolysis and was found to occur in opposite directions (Börsch et al. 2002; Diez
et al. 2004).
The rotation of other subunits has also been observed during ATP hydrolysis such as the
İ- and c-subunits which have been labeled with fluorescent actin filaments (Kato-Yamada et al.
1998; Sambongi et al. 1999; Pänke et al. 2000). However, rotation of the c-subunit was also
observed for detergent-solubilized FoF1-ATP synthase with inactivated Fo. It was shown that
detergents disrupt the FoF1 complex and F1 could hydrolyze ATP regardless of the state of Fo.
Therefore, the rotation of the c-subunit observed in this study and the previous ones could have
been an artifact (Tsunoda et al. 2000). However, rotation of the c-subunit was later proved in a
crosslinking study in which the Ȗ-İ- and c-subunits were crosslinked which did not affect ATP
synthesis or hydrolysis (Tsunoda et al. 2001). Furthermore, the rotation of a single molecule of
intact FoF1 was observed during ATP hydrolysis by attaching an 80-nm colloidal gold
nanoparticle to the c-subunit of the immobilized FoF1. It was found that FoF1 performs ~350
revolutions per second at 37 °C and ~650 revolutions per second at 45 °C. The rotational
behavior of FoF1 resembled that of F1 which meant that Fo did not impose significant drag during
ATP-driven rotation of FoF1 (Ueno et al. 2005). The stepwise rotDWLRQRIWKHİ-subunit has been
observed during ATP synthesis and hydrolysis with single-molecule FRET using FoF1 from E.
coli DQGLQFRUSRUDWHGLQWROLSRVRPHVUHYHDOLQJDMRLQWURWDWLRQIRUWKHȖİ-complex (Zimmermann
et al. 2005, 2006).
In all the previous studies, the enzyme was either immobilized on Ni-NTA-coated glass
slides or incorporated into liposomes which are artificial environments. In addition, in previous
FRET experiments, the FRET partners used were non-specific organic fluorophores, which did
not allow their use in vivo. Only one group has observed the rotation of the a- and ȕ-subunits
relative to the c-subunit using membrane-embedded FoF1 (Tanabe et al. 2001; Nishio et al. 2002).
The membrane fragments were immobilized on a glass slide through a His-tag connected to the
2

c-subunit. The results of their experiments suggested that the rotor and stator in ATP synthase
are interchangeable depending on the immobilized subunit. Another group observed the rotation
of the Fo motor with crosslinking studies using inverted membrane vesicles which also represent
an in vivo-like environment (Suzuki et al. 2002).
Fluorescent labeling of proteins is usually carried out by reacting single cysteine residues
of the target protein with thiol-reactive organic fluorophores (Hermanson 1996). Cysteine is very
attractive since it is relatively rare in proteins and can be easily introduced into a protein by sitedirected mutagenesis. Other reactive amino acids are too abundant in proteins and will not allow
site-specific labeling of the target protein. The labeling is carried out in vitro after purifying the
protein. To study labeled proteins inside living cells, the protein has to be purified, labeled, repurified, and then reintroduced into the cell by either electroporation or microinjection, both of
which are invasive techniques. Therefore, these studies are limited. The target protein cannot be
labeled in vivo, since the fluorophores are non-specific and will bind to any available thiol
groups in all proteins. To solve this problem, fluorescent proteins such as green fluorescent
protein (GFP) have been used instead of organic fluorophores (Tsien 1998). These proteins are
genetically fused to the target protein. Although this type of labeling is site-specific, however,
fluorescent proteins are very large (~30 kDa) and can often be larger than the target protein itself
disrupting the structure and function of the protein (Adams and Tsien 2008). These factors have
led to the development of new protein labeling methods that are more specific and can be used in
vivo. The tetracysteine-biarsenical system is an innovative technique, developed by Tsien and
colleagues in 1998, for labeling proteins in live cells (Griffin et al. 1998). This system is based
on the fact that arsenoixdes have a high affinity for closely-spaced cysteine pairs. Therefore,
fluorescein arsenical hairpin binder-ethanedithiol (FlAsH-EDT2) was designed which is a
biarsenical fluorescein derivative and binds with high affinity to a motif made up of a rare sixamino acid sequence containing four cysteine residues (CCPGCC) (Griffin et al. 1998; Adams et
al. 2002). This makes FlAsH highly specific and allows its use in labeling of proteins in intact
cells. FlAsH is also membrane permeant and non-fluorescent by itself but becomes fluorescent
only when bound to its motif (Griffin et al. 1998; Adams et al. 2002). Therefore, FlAsH-labeling
causes minimal background fluorescence. Figure 2 shows the structure of FlAsH-EDT2
(Invitrogen 2010). Furthermore, the FlAsH dye is small in size and therefore does not disrupt the
structure or function of the enzyme. Figure 3 shows the difference in size between GFP and the
3

biarsenical-tetracysteine complex (Zhang et al. 2002). FlAsH emits green fluorescence (peak at
~528 nm) and is a good FRET acceptor from cyan fluorescent protein (CFP) (Figure 4)
(Hoffman et al. 2005; Adams and Tsien 2008). In this project, the a-subunit of ATP synthase was
IXVHGWR&)3ZKLOHWKHȖ-subunit was labeled with FlAsH and FRET experiments were carried
out to observe the in vivo rotation of the enzyme.
In the phenomenon of FRET, there are two fluorophores, one acting as the donor and the
other one as the acceptor (Didenko 2001). When the donor is excited, non-radiative excitation
energy is transferred (through dipole-dipole interactions) from the donor to the acceptor which in
turn gets excited and emits fluorescence. Thus, FRET causes the fluorescence intensity of the
donor to decrease and that of the acceptor to increase. For FRET to occur, two conditions must
be present. First, the emission spectrum of the donor must overlap with the absorption spectrum
of the acceptor. This criterion is fulfilled with CFP and FlAsH. Secondly, the donor and acceptor
should be within a certain distance known as the Förster radius (typically less than 10 nm). The
Förster radius is defined as the distance between the donor and acceptor at which energy transfer
efficiency is 50%. This criterion is also satisfied in ATP synthase since the diameter of the F1
motor, which is the bulkiest part of the enzyme, is 10 nm (Lengeler et al. 1999). Therefore, two
fluorophores in the same plane or close to each other will not exceed the 10 nm range allowing
FRET to take place.
ATP synthase is an important enzyme since it also represents a potential drug target for
the diarylquinolines (DARQs), a new class of anti-tuberculosis drugs. Tuberculosis is an airborne
infectious disease that attacks the respiratory system and other organs resulting in an annual
death of more than 1.7 million people (TB Alliance 2010). Almost one-WKLUGRIWKHZRUOG¶V
population is latently infected with Mycobacterium tuberculosis and every second someone is
newly infected (WHO 2010a). HIV infection causes individuals to become more susceptible to
tuberculosis infection or causes a latent infection to activate (Rosas-Taraco et al. 2006). In
addition, co-infection speeds up the progress of both infections making tuberculosis a main cause
of death among HIV-infected patients (Goletti et al. 1996; Mariani et al. 2001; TB Alliance
2010). The recommended standard treatment for tuberculosis requires the administration of four
drugs: isoniazid, rifampicin, pyrazinamide and ethambutol or streptomycin for two months
followed by isoniazid and rifampicin alone for four more months (WHO 2010b). For latent
tuberculosis, the standard treatment is nine months of isoniazid alone (CDC 2000). The
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mechanism of action of each drug is listed in table 1 (Rivers and Mancera 2008). However, these
current anti-tuberculosis drugs are not very effective against dormant, non-replicating bacteria
associated with latent tuberculosis. Furthermore, multi-drug resistant (MDR) and extensively
drug resistant (XDR) strains have emerged (Rivers and Mancera 2008). MDR-tuberculosis is
defined as tuberculosis which is resistant to at least isoniazid and rifampicin, the two most
powerful first-line drugs. XDR-tuberculosis has resistance to isoniazid and rifampicin as well as
second-line drugs and is almost incurable. Therefore, there is an urgent need for the development
of new anti-tuberculosis drugs.
The DARQ lead compound, TMC207 (Figure 5), is able to inhibit both drug-sensitive
and drug-resistant M. tuberculosis in vitro and in vivo (Andries et al. 2005) and can efficiently
kill replicating as well as dormant mycobacteria. This makes DARQs potentially superior to the
current anti-tuberculosis drugs (Koul et al. 2008; Rao et al. 2008). TMC207 was found to inhibit
the bacteria by binding to subunit-c of ATP synthase (Koul et al. 2007). Furthermore, TMC207
is also highly selective towards mycobacterial ATP synthase with a 50% inhibitory concentration
(IC50) of 10 nM as opposed to an IC50 of >200 µM with human mitochondrial ATP synthase
(Haagsma et al. 2009). Therefore, DARQs are unlikely to induce mitochondrial toxicity in
mammalian cells and are promising drug candidates. However, it is not known how DARQs
interfere with the catalytic cycle of ATP synthase. This information will be very useful for the
design of novel ATP synthase inhibitor drug candidates. Insight in DARQ action may be
obtained by single-molecule investigation of ATP synthase rotation. Since an experimental
system for single-molecule analysis of mycobacterial ATP synthase is not available, therefore, in
our experiments we used E. coli ATP synthase which is an established model system for singlemolecule analysis. However, E. coli does not show susceptibility to DARQs at whole cell level
(Andries et al. 2005), but it is not known if this resistance stems from lack of binding of DARQs
to E. coli ATP synthase or from a lower importance of ATP synthase in E. coli metabolism
compared to M. tuberculosis. In this project we tested if E. coli ATP synthase is susceptible to
two different DARQ compounds.

5

2. INTRODUCTION
7KHLPSRUWDQFHRI$73V\QWKDVHOLHVLQWKHIDFWWKDWLWLVWKHZRUOG¶VVPDOOHVWELRORJLFDOPRWRU
and it is also a potential drug target for DARQs. For those two reasons, two sets of experiments
were carried out. The aim of the first set of experiments was to label ATP synthase with sitespecific fluorescent tags, which would allow the monitoring of the dynamics of ATP synthase
using FRET measurements in an in vivo environment. Therefore, the a-subunit of ATP synthase
ZDVIXVHGWR&)3ZKLOHWKHȖ-subunit was incorporated with the tetracysteine FlAsH motif
(CCPGCC) (Adams et al. 2002) to allow FlAsH to bind. If the enzyme was found functional
after labeling, the ability of the introduced fluorophores for FRET would be determined.
Subsequently, the nucleotide-dependency of FRET efficiency would be tested in inverted
membrane vesicles and in whole E. coli cells to test suitability of this in vivo system as a
potential marker for bacterial metabolism and to evaluate the possibility of a favored resting
position for this enzyme.
The aim of the second set of experiments was to test the inhibitory effects of two selected
DARQs (referred to as compound 1 and compound 2 in this report) on ATP synthesis in inverted
membrane vesicles of E. coli. This would help in understanding why E. coli ATP synthase is
resistant to DARQs at whole cell level. Furthermore, if inhibition of ATP synthesis occurred, this
would allow the future use of E. coli ATP synthase as a model system in understanding the
mechanism of inhibition of DARQs using single-molecule FRET analysis. For this experiment,
we used the E. coli RA1 strain which is well suitable for single-molecule fluorescence analysis
due to low background fluorescence. In addition, the a-subunit of ATP synthase was fused to
enhanced green fluorescent protein (EGFP).

6

3. MATERIALS AND METHODS
Experiments for observation of in vivo rotation of ATP synthase:
3.1 Bacterial Strain I
ATP synthase was over-expressed in E. coli DK8 cells ǻ uncB-C), which lack the genes that
code for the a- and İ-subunits of ATP synthase (Klionskv et al. 1984), using the PLZR10
expression plasmid. This plasmid codes for ATP synthase of the thermophilic Bacillus PS3,
hence, stable at room temperature, with CFP fused to the C-terminus of the a-subunit of the
enzyme and the tetracysteine FlAsH PRWLI &&3*&& LQFRUSRUDWHGLQWRWKHȖ-subunit. As for the
controls, PLZR9 plasmid was used to code for ATP synthase with CFP fused to the a-subunit.
PLZR4 plasmid was used to code for ATP synthase with the FlAsH motif incorporated into the
Ȗ-subunit. PLZR10, PLZR9, and PLZR4 plasmids were all prepared by Dr. Zorica Ristic, VU
University Amsterdam, the Netherlands. The plasmid pTR19-ASDS, prepared by Dr. Toshiharu
Suzuki, Tokyo Institute of Technology, was used to code for ATP synthase lacking both CFP
and the FlAsH motif. This control will be referred to as wild-type (wt) throughout the text.

3.2 Preparation of Electrocompetent Cells
A 5 mL LB [1% (w/v) tryptone (Oxoid, UK), 0.5% yeast extract (Oxoid), 1% NaCl (SigmaAldrich, Germany)] starter culture of E. coli DK8 cells was incubated overnight at 37°C with
vigorous shaking. The following day, the culture was inoculated into 500 mL LB medium and
the cells were incubated at 37°C at 180 rpm for ~5 hours until the OD600 nm was 0.635. The cells
were then spun down at 8000 rpm using a JA-10 rotor (Beckman Coulter, Germany) for 5 min at
4°C and the pellet was resuspended in 500 mL ice-cold 10% glycerol (Sigma-Aldrich). This step
was repeated three times with resuspension in 250 mL ice-cold 10% glycerol followed by 85 mL
and finally 1-2 mL. Aliquots of 50 µL were then prepared and snap-frozen in liquid nitrogen and
stored at -80°C for later use.

3.3 Electroporation of Electrocompetent E. Coli DK8 Cells
Electrocompetent E. coli DK8 cells were transformed with the following four plasmids: PLZR4
&\VȖ , PLZR9 (aECFP), PLZR10 (aECFP- &\VȖ and pTR19:ASDS (wt). 1-3 µL of each
plasmid were transferred to an eppendorf tube containing 50 µL electrocompetent E. coli DK8
cells. The plasmid-cells mixture was then pipetted into an electroporation cuvette and placed in
7

the electroporator where the cells were zapped (voltage = 1.8 kilovolts). Around 300 µL of SOC
solution was added to each mixture and transformed cells were incubated at 37°C for ~1 hour.
The transformed cells were then plated onto LB plates [1% (w/v) tryptone , 0.5% yeast extract,
1% NaCl, 1.5% bacteriological agar (Sigma-Aldrich)] containing ampicillin (Sigma-Aldrich) and
incubated overnight at 37°C.
The SOC solution was prepared by adding 97 mL water to 2 g tryptone, 0.55 g yeast
extract, 1 mL 1 M NaCl, and 0.25 mL 1 M KCl (Sigma-Aldrich). This solution was then
autoclaved and cooled to 55°C. Then, sterile solutions of 1 mL 1 M MgCl2 (Sigma-Aldrich), 1
mL 1 M MgSO4 (Sigma-Aldrich) and 1 mL 2 M glucose (Baker, the Netherlands) were added
and the pH was adjusted to 7.0. The SOC solution was then divided into aliquots and stored at
-20 °C.

3.4 Preparation of Inverted Membrane Vesicles
A 5 mL 2xYT [1.6% (w/v) tryptone, 1% yeast extract, 0.5% NaCl] starter culture containing
ampicillin (final concentration = 100 µg/mL) was incubated for ~6-7 hours at 37°C and 220 rpm.
The culture was then inoculated into 500 mL 2xYT medium containing ampicillin and incubated
overnight at 37°C and 220 rpm. The following morning, the cells were spun down at 9000 rpm
and 4°C for 15 min (rotor = JA-10). Cell pellets were resuspended with cold PA3 buffer [10 mM
HEPES-KOH (Sigma-Aldrich), 5 mM MgCl2, 10% glycerol, pH 7.5] containing the protease
inhibitor, Pefabloc (Roche, Germany) using 7 mL buffer per 1 gram of cells. The cells were
broken using the One Shot Cell Disrupter (Constant Systems, UK) after optimizing the
conditions (single pass, pressure = 0.8 kbar). Cell debris and intact cells were spun down at 4000
rpm and 4°C for 20 min using a Beckman tabletop centrifuge. The supernatant containing the
inverted membrane vesicles was then spun down at 55,000 rpm and 4°C for 1 hour using a
Beckman ultracentrifuge and the 70 Ti rotor. Cell pellets were resuspended with cold PA3 buffer
(1 mL) using a glass homogenizer. The sample was then divided into aliquots and snap-frozen
using liquid nitrogen and stored at -80°C for later use. All previous steps were carried out in ice
to ensure the stability of the vesicles.
Protein concentration of the four constructs was determined using the Bradford method
(Bradford 1976). In this method, a solution of Coomassie brilliant blue G250 dye (SigmaAldrich) in dilute acid is added to the protein sample where it binds to the proteins and changes
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color from brownish-orange (cationic form) to blue (anionic form). The absorbance of the
mixture can then be measured at 595 nm and is directly proportional to the concentration of the
bound dye and hence the concentration of proteins in the sample. Duplicate samples of serial
dilutions (0, 10, 20, 30, and 40 µL) of a standard protein of known concentration [bovine serum
albumin (Sigma-Aldrich), 1 mg/mL] were added to a fixed volume of the dye (500 µL) and MQ
water in 1 mL total volume. Absorbance was measured at 595 nm and a standard curve of
absorbance versus protein concentration was constructed. Protein samples of the four constructs
were measured at 595 nm and their concentrations were determined using the standard curve.

3.5 CFP Fluorescence Detection
For each construct, in a 1.5 mL cuvette, 200 µL membrane vesicles was added to 400 µL buffer
PA4 (10 mM HEPES-KOH, 100 mM KCl, 5 mM MgCl2, pH 7.5). As a control, 10 µL CFP was
added to 990 µL buffer PA4. The CFP plasmid was prepared by Dr. Zorica Ristic, VU
University Amsterdam, the Netherlands. Fluorescence was measured for the five samples using a
Varian Cary Eclipse fluorescence spectrophotometer (Germany) with the excitation wavelength
set at 434 nm.

3.6 Proton Transport Assay
For each construct, in a 1.5 mL cuvette, 1.28 µL of 1 mM ACMA (Sigma-Aldrich) solution
[dissolved in ethanol (Sigma-Aldrich)] was added to 1 mL buffer PA4 which was preheated in a
water bath at 37°C. The cuvette was placed in the Varian Cary Eclipse fluorescence
spectrophotometer where the excitation and emission wavelengths of ACMA were set at 410 and
480 nm, respectively and measurement was started. After ~2 min, 20 µL of membrane vesicles
was added and when the baseline was constant, 15 µL of 200 mM ATP (AppliChem, Germany)
solution (dissolved in MQ water and pH adjusted to 7.5 using NaOH) was then added. After ~ 12
min, 2.8 µL of 1 mM of an uncoupler solution, SF6847 (Sigma-Aldrich), which was dissolved in
ethanol was added. Measurement was stopped after ~5 min.

3.7 Site-Specific Labeling and FRET Assay in Membrane Vesicles
After optimization of conditions and reagent concentrations, site-specific labeling was carried
out as follows: to a 1.5 mL cuvette, 780 µL of buffer PA4, 20 µL of 50 mM TCEP (Pierce, USA)
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solution, 100 µL of 50 mM MES (AppliChem) solution, 50 µL of membrane vesicles containing
wt construct, and 50 µL of 100 µM FlAsH-EDT2 solution (dissolved in buffer PA4) were added.
TCEP and MES were dissolved in MQ water. The FlAsH dye was provided as a gift by Dr.
Stephen Adams from the University of California, San Diego. The volumes of buffer PA4 and
the vesicles were adjusted such that all four constructs had the same final protein concentration
of ~1 mg/mL. Fluorescence was measured for each sample once after excitation at 434 nm and
once at 508 nm at 0, 60 and 120 min. The cuvettes were covered with parafilm and stored in an
incubator at 37°C between measurements to prevent evaporation of the samples.

3.8 Addition of Nucleotides to FlAsH-Labeled Membrane Vesicles
After two hours of FlAsH-labeling of the four constructs, 20 µL of buffer PA4 was added to each
sample and fluorescence was measured at 434 nm and 508 nm. The same experiment was
repeated four more times with the addition of 20 µL of 100 mM ADP (AppliChem) solution, 20
µL of 100 mM AMP-PNP (Sigma-Aldrich) solution, 20 µL of 100 mM ATP solution, and finally
20 µL of 100 mM GTP (AppliChem) solution. Fluorescence measurements were carried out at
434 nm and 508 nm. All the solutions of the nucleotides were dissolved in buffer PA4.

3.9 Preparation of Whole Cells
A 5 mL 2xYT starter culture containing ampicillin (final concentration = 100 µg/mL) was
incubated for ~6-7 hours at 37°C and 220 rpm. The culture was then inoculated into 500 mL
2xYT medium containing ampicillin and incubated overnight at 37°C and 220 rpm. The
following morning, the cells were spun down at 4000 rpm and 4°C for 20 min using the tabletop
centrifuge. Cell pellets were resuspended with cold PA3 buffer containing Pefabloc using 7 mL
buffer per 1 gram of cells.

3.10 Streaking Plates with FlAsH-Labeled Whole Cells
The following reagents were added to a cuvette: 140 µL buffer PA4, 10 µL of 50 mM TCEP
solution, 50 µL of 50 mM MES solution, 250 µL of bacterial whole cells containing the PLZR10
plasmid (aECFP- &\VȖ DQG/RI100 µM FlAsH-EDT2 solution. As a control, the same
amounts of reagents were added to another cuvette but 50 µL of buffer was added instead of
FlAsH-EDT2. Both cuvettes were incubated at 37°C for ~3 hours. An LB plate containing
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ampicillin was streaked with ~3 µL of one sample and another plate was streaked with ~3 µL of
the other sample. Both plates were left overnight in an incubator at 37°C.

3.11 Site-Specific Labeling and FRET Assay in Whole Cells
After optimization of reagent concentrations, to a 1.5 mL cuvette, 480 µL buffer PA4, 20 µL of
50 mM TCEP solution, 100 µL of 50 mM MES solution, 300 µL of bacterial whole cells
containing the PLZR9 plasmid (aECFP), and 100 µL of 100 µM FlAsH-EDT2 solution were
added. To another 1.5 mL cuvette, 280 µL buffer PA4, 20 µL of 50 mM TCEP solution, 100 µL
of 50 mM MES solution, 500 µL of bacterial whole cells containing the PLZR10 plasmid
(aECFP- &\VȖ , and 100 µL of 100 µM FlAsH-EDT2 solution were added. The volumes of
buffer and whole cells were adjusted such that both constructs displayed the same fluorescence
intensity of CFP and thus had approximately the same protein concentration. Fluorescence was
measured for each sample once at 434 nm and once at 508 nm at 0, 60 and 120 min. The cuvettes
were covered with parafilm and stored in incubator at 37°C between measurements. After two
hours of FlAsH-labeling, 20 µL of 100 mM ATP solution (dissolved in buffer PA4) was added to
both samples and fluorescence was remeasured at 434 nm and 508 nm.

3.12 Incubation with Glucose
The FRET assay was repeated once more where 280 µL buffer PA4, 20 µL of 50 mM TCEP
solution, 100 µL of 50 mM MES solution, 500 µL of bacterial whole cells containing the
PLZR10 plasmid (aECFP- &\VȖ , and 100 µL of 100 µM FlAsH-EDT2 solution were added to a
1.5 mL cuvette. The same volume of each reagent was added to another cuvette. Fluorescence
was measured for both samples at 434 nm at 0, 60 and 120 min. After two hours of FlAsHlabeling, 25 µL of 1 M glucose solution was added to one sample to achieve a final concentration
of 25 mM glucose. As a control, 25 µL of buffer PA4 was added to the other sample. Both
samples were incubated in a water bath at 37°C with shaking at 300 rpm for 30 min and
fluorescence was measured again at 434 nm. Samples were incubated once more at 37°C and
fluorescence was remeasured at 70 min and 220 min.
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Experiments for testing the inhibitory effects of diarylquinolines:
3.13 Bacterial Strain II
ATP synthase was over-expressed in E. coli RA1 cells (unc-/cyo-), which lack the FoF1 genes and
genes coding for cytochrome c oxidase (Aggeler et al. 1997), using the pSD166 expression
plasmid. This plasmid codes for the E. coli ATP synthase with EGFP fused to the C-terminus of
the a-subunit of the enzyme. The E. coli RA1 cells transformed with the pSD166 plasmid were
provided by Dr. Michael Borsch from Stuttgart University, Germany.

3.14 Preparation of Inverted Membrane Vesicles
Three different batches of inverted membrane vesicles of E. coli RA1 strain harboring the
pSD166 plasmid were prepared using the same protocol described in section 3.4. Protein
concentrations of the three batches were determined using the Bradford method described in
section 3.4.

3.15 GFP Fluorescence Detection
In a 1.5 mL cuvette, 200 µL membrane vesicles of each batch was added to 400 µL buffer PA4
and fluorescence was measured using the Varian Cary Eclipse fluorescence spectrophotometer
with the excitation wavelength set at 480 nm (specific for GFP).

3.16 ATP Synthesis Assay
The ATP synthesis assay was used to measure ATP synthesis and to test the inhibitory effects of
compound 1 and compound 2 on E. coli ATP synthase. All samples contained inverted
membrane vesicles of the E. coli RA1 strain with a protein concentration of 0.2 mg/mL, MOPS
buffer [50 mM MOPS (AppliChem), 2 mM MgCl2, pH 7.5], 11.8 U/mL hexokinase (SigmaAldrich), 100 µM diadenosine pentaphosphate (Sigma-Aldrich), 2 mM ADP, 25.4 mM glucose,
and 20 mM KH2PO4 (Sigma-Aldrich). In total, there were 14 samples. Nine samples contained 5
µL of compound 1 dissolved in DMSO (Sigma-Aldrich) with different concentrations (0.1, 1, 5,
10, 17.5, 25, 50, 100 and 200 µM). As a control, 0.5 µL of 25 mM DCCD (Sigma-Aldrich)
dissolved in ethanol was added to the tenth sample. To make sure that the solvents had no
LQKLELWRU\HIIHFWVRQ$73V\QWKHVLVȝ/RI'062ZDVDGGHGWRVDPSOHDQGȝ/RI
ethanol was added to sample 12. 10 µL of 250 mM NADH (AppliChem) was added to all
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samples to start the reaction except one sample (sample 13) representing the background control
(residual ATP). Sample 14 contained NADH without compound 1 and was used as the positive
control representing maximum activity. All 14 samples were incubated in a water bath at 37°C
and 300 rpm for 20 minutes. Reaction was stopped by adding 25 µL of 0.5 M EDTA (SigmaAldrich) to all the samples which were then transferred to ice. Samples were boiled for 5 min and
centrifuged at 10,000 rpm for 20 min to get rid of denatured proteins. The synthesized glucose-6phosphate is heat stable and does not denature upon boiling and remains in the supernatant. To
start the ATP synthesis measurements, in a quartz cuvette, 2600 µL of MOPS buffer, 400 µL of
the supernatant, and 30 µL of 250 mM NADP+ (AppliChem) were added and mixed well. Using
a Varian spectrophotometer with a wavelength set at 340 nm, NADP+ was monitored for 1 min.
7RVWDUWWKHUHDFWLRQȝ/RI8P/JOXFRVH-6-phosphate dehydrogenase (Sigma-Aldrich)
was added and NADPH was produced. The same protocol was followed for compound 2 using
DOVRȝ/RIGLIIHUHQWFRQFHQWUDWLRQV (0.1, 1, 10, 25, 50, 100, and 200 µM).
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4. RESULTS
Experiments for observation of in vivo rotation of ATP synthase:
4.1 Functionality of the CFP-ATP Synthase Fusion
In order to test the functionality of ATP synthase with site-specific fluorophores, inverted
membrane vesicles were prepared from whole cells (Figure 6). The vesicles have their F1 parts
on the outside of their membranes and this is necessary to be able to carry out the proton
transport assay described in section 3.6. The constructs were then tested for CFP fluorescence
emission since CFP is fluorescent only when correctly folded (Reid and Flynn 1997; Craggs
2009). The constructs that had the CFP fusion (aECFP- &\VȖDQGaECFP) displayed the two
maximum peaks characteristic of CFP at 475 nm and 502 nm7KHRWKHUWZRFRQVWUXFWV &\VȖ
and wt) that lacked CFP did not display the two peaks (Figure 7). This result indicates that CFP
is correctly folded and functional in the fusion protein.
The next step was to ensure that ATP synthase in all four constructs was active and
functional. Therefore, proton transport was monitored in each construct by fluorescence
quenching of ACMA, a pH sensitive dye. Since the vesicles have their F1 parts on the outside,
they will be to hydrolyze the added ATP. Figure 8 shows the structure of ACMA which is a
derivative of 9-AA. The vesicles were added to a solution of ACMA in buffer PA4. Reaction
was initiated upon addition of ATP inducing ATP hydrolysis and causing protons to be pumped
inside the vesicles which resulted in the quenching of ACMA. Upon addition of SF6847, an
uncoupler, holes were formed in the membranes dissipating the pH gradient and restoring the
fluorescence of ACMA. Figure 9 shows how proton transport is measured by fluorescence
quenching of 9-AA (Taiz and Zeiger 2010). Figure 10 shows ACMA quenching between 7580% for the four constructs which proves their activity. This experiment shows that ATP
synthase is fully active in all four constructs before labeling with the second site-specific
fluorophore.

4.2 Site-Specific Labeling and FRET in Membrane Vesicles
In order to introduce the second site-specific fluorophore, the four constructs were labeled with
FlAsH-EDT2 for two hours. The FRET signal was then measured at 0, 60, and 120 min once
after excitation at 434 nm (specific for CFP) and once at 508 nm (specific for FlAsH). Figure 11
shows the fluorescence intensity of aECFP- &\VȖQormalized to the wt (at 434 nm). After two
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hours of FlAsH-labeling, the CFP peak (~475 nm) decreased and the FlAsH peak (~530 nm)
appeared indicating successful FlAsH-labeling and FRET occurrence from CFP to FlAsH. The
results of each construct alone at 434 nm are shown in Figure 12 and at 508 nm are shown in
Figure 13. To ensure the activity of the membrane vesicles after two hours of FlAsH-labeling,
proton transport measurements were carried out again. Figure 14 shows that the activity of the
four constructs decreased after labeling, however, they were still active. These results show that
ATP synthase after labeling with two site-specific fluorophores was still functional. Furthermore,
energy transfer was successfully observed between the two fluorescent labels.

4.3 Nucleotide-Dependency of FRET Signal in Membrane Vesicles
Nucleotide-dependency of FRET efficiency is expected if ATP synthase displays one favorite
resting state. Upon addition of ATP, the enzyme undergoes hydrolysis and its rotation should be
detected by a change in the FRET signal before and after the addition of ATP. For this
experiment, 2 mM nucleotides were separately added to each of the four constructs after two
hours of FlAsH-labeling and changes in the FRET signal were observed. Figure 15 shows the
results of this experiment using aECFP- &\VȖDWQP. The ratio of the fluorescence intensity
of the donor to that of the acceptor (ID/IA) was calculated for each case with the donor peak
chosen at 475 nm and the acceptor peak at 528 nm. The ID/IA before and after the addition of
buffer PA4, 2 mM ADP, 2 mM AMP-PNP, and 2 mM GTP was almost the same. However,
upon addition of 2 mM ATP, the ID/IA significantly changed from 0.81 to 1.10. Figure 16 shows
the results of excitation at 508 nm where there is a significant decrease (around 60%) in the
FlAsH peak (Figure 16-D) upon addition of ATP. The results of the control experiments (wt,
&\VȖDQGDECFP) at 434 nm and 508 nm are shown in Figures 17 through 22. These results
show that the FRET signal changes upon addition of ATP which might be due to the rotation of
the enzyme and hence the presence of a favorite resting position.

4.4 Nucleotide-Dependency of CFP Signal
In order to ensure that the effect of nucleotides on the FRET signal is due to the rotation of the
enzyme and not an artifact, the effect of nucleotides on CFP alone was investigated.
Fluorescence was measured before and after the separate addition of 2 mM ADP, 2 mM AMP-
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PNP, 2 mM ATP, and 2 mM GTP to CFP (excitation wavelength = 434 nm). A greater decrease
in the fluorescence intensity of the CFP signal was observed upon addition of ATP (Figure 23).
When 10 mM ATP and 10 mM ADP were separately added to CFP, a significant
decrease in the CFP signal was observed with ATP. Figure 24 shows quenching of 25%, 34%,
and 50% for buffer PA4, ADP and ATP, respectively. These results show that ATP has a
quenching effect on the CFP signal and this means that the nucleotide-dependency of the FRET
signal that was previously observed is not entirely due to the rotation of the enzyme.

4.5 Effect of FlAsH-EDT2 on Whole Cells
The effect of FlAsH-EDT2 on the survival of whole bacterial cells was tested since FlAsH
contains arsenic which could be toxic to the cells. In order to do that, one plate was streaked with
a solution of whole cells (harboring the construct aECFP- &\VȖ) and 50 µL of FlAsH-EDT2 and
another plate was streaked with a solution containing 50 µL of buffer PA4 as a control. Figure 25
shows that there was no significant difference in the number of cells between the two plates
which meant that FlAsH does not kill the bacterial cells.
FRET is difficult to observe in whole bacterial cells due to scattering as a result of the
cytoplasmic constituents. However, we tried to test the FRET efficiency in whole cells using the
two constructs, aECFP- &\VȖDQGDECFP. The FRET signal was measured at 0, 60, and 120 min
once using an excitation wavelength of 434 nm and once at 508 nm. Figure 26 shows the FRET
signal after two hours of FlAsH-labeling. The FlAsH peak (~530 nm) increases in aECFP- &\VȖ,
however, the CFP peak (~475 nm) decreases in both constructs. This result shows successful
FlAsH-labeling in whole cells and the possibility of FRET occurrence from CFP to FlAsH.
Since ATP was found to have a quenching effect on the FRET signal in membrane
vesicles, we sought to develop an ATP biosensor using whole cells. In order to do that, after two
hours of FlAsH-labeling, 2 mM ATP was added to the two constructs (aECFP and aECFP&\VȖ 7KH,D/IA before and after the addition of ATP was almost the same for the two
constructs and there was no significant change in the FRET signal (Figure 27). These results
suggest that the whole cells might be insensitive to the external addition of ATP since the
catalytic sites are on the inside of the cells. Therefore, the cells were incubated with glucose to
induce the production of ATP from within the cells. After two hours of FlAsH-labeling, 25 µL
glucose (final concentration = 25 mM) was added to one sample containing bacterial cells
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harboring the construct aECFP- &\VȖ. As a control, 25 µL of buffer PA4 was added to another
sample. Both samples were incubated at 37°C and the FRET signal was measured after 30, 70,
and 220 min at 434 nm (Figure 28). Although the signal changes over time with a significant
increase in the FlAsH peak, however, the graphs show no difference between the addition of
glucose and the control experiment (addition of buffer PA4). This might be because the
concentration of the glucose was too low.

Experiments for testing the inhibitory effects of diarylquinolines:
4.6 Inhibitory Effects of DARQs on ATP Synthesis in E. Coli
In order to test the inhibitory effects of DARQs on ATP synthesis in E. coli, three batches of
inverted membrane vesicles of E. coli RA1 harboring the pSD166 plasmid were prepared, and
GFP fluorescence was measured using an excitation wavelength of 480 nm. Figure 29 shows that
the three batches contained the characteristic maximum peak of GFP which is at ~506 nm. This
result indicates that GFP is correctly folded and functional in the fusion protein.
The ATP synthesis assay was then carried out to test the inhibitory effect of compound 1 on
E. coli ATP synthase. Figure 30 shows the reactions of the ATP synthesis assay. Three
independent experiments using the three different batches were carried out. Figure 31 shows the
raw data of one of those experiments. After the addition of glucose-6-phosphate dehydrogenase,
the sample lacking NADH showed little ATP synthesis since no NADPH was produced. The
positive control showed maximum activity while DCCD, an inhibitor of oxidative
phosphorylation, inhibited ATP synthesis, indicating functionality of this assay system. Figure
32 shows the mean values of the three experiments including standard deviation. At nanomolar
concentrations, no significant inhibitory effect was visible. However, at elevated micromolar
concentrations, compound 1 displayed dose-dependent inhibition of ATP synthesis with an IC50
of approximately 25 µM.
The ATP synthesis assay was also used to test the inhibitory effect of compound 2 on E. coli
ATP synthase. Figure 33 shows the mean values of three independent experiments using
standard deviation. Compound 2 did not show any inhibition of ATP synthesis when the
experiments were carried out using MOPS buffer. When the experiments were repeated with
buffer PA4, some inhibition occurred (Figure 34). The inhibitory effect, however, was lower
compared to compound 1 with an IC50 > 50 µM and the dose-dependency was less pronounced.
17

5. DISCUSSION
Two sets of experiments were carried out in which the aim of the first set was to label ATP
synthase using site-specific fluorescent tags. This would allow the observation of its in vivo
rotation and to investigate the possibility of the presence of a favored position during the resting
phase of the enzyme. The aim of the second set of experiments was to test the inhibitory effects
of two DARQs on ATP synthesis in E. coli.
In the first set of experiments, the a-subunit of ATP synthase was fused to CFP while the
Ȗ-subunit was labeled with the FlAsH dye which is highly specific since it only binds to its
tetracysteine motif (CCPGCC) which was incorporated into the Ȗ-subunit. The high specificity of
the FlAsH dye allowed its use in vivo which could not be carried out with other non-specific
organic fluorophores. In addition, its small size did not disrupt the structure or function of the
enzyme. The results showed that CFP was correctly folded and functional in the fusion protein
and that ATP synthase was fully active in all four constructs after labeling with FlAsH as shown
by the proton transport experiments in Figure 14. Therefore, site-specific labeling of ATP
synthase in inverted membrane vesicles was successful. Furthermore, FRET was successfully
observed from CFP to FlAsH (Figure 11).
The next step was to investigate the presence of a favored resting position for the
enzyme. Mellwig and Bottcher (2003) established a three-dimensional map of ATP synthase
from chloroplasts with a 20-Å resolution using electron cryomicroscopy data. This map provides
a scaffold for fitting the known homology models of various subunits. It was suggested that in
the inactive enzymeWKHȖ-subunit had a unique resting position relative to the side stalk in which
the side stalk interacts with one specific Į-subunit (Mellwig and Bottcher 2003). In this study, we
tried to prove experimentally the presence of such a favored resting position in E. coli ATP
synthase.
The rotation of the enzyme was observed by measuring the FRET signal before and after
the addition of 2 mM nucleotides to the constructs. It was expected that in the case of buffer
PA4, ADP and AMP-PNP, which is a nonhydrolyzable ATP analog, the FRET signal would be
more or less the same since the enzyme is inactive in these three cases. In case of ATP, however,
the enzyme undergoes hydrolysis and therefore should give a different signal before and after the
addition of ATP. The buffer, ADP and AMP-PNP, as expected, did not cause any change in the
FRET signal, while the addition of 2 mM ATP indeed caused a significant change in the signal.
18

However, Willemse et al. (2007) found that increasing levels of ATP decreased the fluorescence
intensity of the acceptor in FRET experiments. According to the authors, ATP FDXVHV³DGLUHFW
quenching of the energy-transfer step coupled to energy-induced charge displacement in the
SKRVSKDWHJURXSV´If ATP was acting as a quenched acceptor, then ATP should have a direct
effect on CFP. In order to test this hypothesis, 2 mM nucleotides were added to CFP, and it was
found that ATP indeed showed a greater degree of quenching compared to the other nucleotides.
This was even more evident when 10 mM ATP was added resulting in 50% quenching as
opposed to only 25% and 34% for the buffer and ADP, respectively. The quenching that occurs,
however, is not a result of resonance energy transfer from CFP to ATP since ATP has only one
excitation peak at 260 nm (Dounce et al. 1948) which was verified by us and this absorption
peak does not overlap with the emission spectrum of CFP. Furthermore, ATP seems to have a
quenching effect on all four constructs including the ones that lack CFP as shown in Figures 17
through 20. It is known that ATP itself has fluorescent properties (Amat et al. 2005) and can
quench the fluorescence of some chemical compounds (Li et al. 2005). Therefore, ATP might be
able to quench the fluorescence of the FlAsH dye. This would explain the significant decrease
(around 60%) in the FlAsH peak LQWKH&\VȖFRQVWUXFWZKLFKODFNV&)3(Figure 20-D). Another
possibility would be that ATP is able to bind to FlAsH through the oxygen atoms of its
phosphate groups thus quenching its fluorescence. This could be possible since oxygen and
sulfur have the same valence state. Furthermore, in a previous study, it was suggested that the
hydroxyl group of the monothiol, 2-mercatoethanol could weakly bind to the arsenic atom of
FlAsH (Adams and Tsien 2008). Figure 35 shows a possible structure of FlAsH with ATP
binding to it.
In conclusion, it was difficult to determine whether the change in the FRET signal was
due to the quenching effect of ATP or to the activity of the enzyme. In order to overcome this
obstacle, GTP was used instead of ATP since both GTP and ATP support rotation of the enzyme
(Noji et al. 2001). Addition of GTP to CFP did not show a significant decrease in the signal
which meant that it did not have the same quenching effect of ATP. However, addition of GTP
to the construct did not show any change in the FRET signal either. Therefore, the rotation of the
enzyme and the presence of a favored resting position using inverted membrane vesicles were
difficult to observe with ATP due to its quenching effect. Recently, a favored resting position for
ATP synthases from chloroplasts has been observed using single-molecule FRET experiments
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(Bienert et al. 2009). ,WZDVIRXQGWKDWLQWKHDFWLYHVWDWHWKHȖ-subunit interacts with the three
Įȕ-SDLUVZLWKHTXDOSUREDELOLW\,QWKHLQDFWLYHVWDWHWKHȖ-subunit interacts with only one
VSHFLILFĮȕ-pair which is in agreement with Mellwig DQG%RWWFKHU¶VVXJJHVWion (Bienert et al.
2009).
The same experiments were repeated with whole bacterial cells where site-specific
labeling was successful and FRET could be possible. However, a greater concentration of FlAsH
was required to achieve a recognizable signal. We sought to develop an ATP biosensor using
whole cells of E. coli by taking advantage of the quenching effect of ATP. First, 2 mM ATP was
added to the whole cells after two hours of FlAsH-labeling, however, no change in the FRET
signal occurred. This might have been because the F1 parts, containing the catalytic sites, are on
the inside of the bacterial cells making them insensitive to the external addition of ATP. This
meant that the cells had to produce their own ATP from the inside for the FRET signal to
change. In order to do that, the cells were incubated with glucose and the signal was measured
after 30, 70, and 220 min (Figure 28). The FRET signal changed over time with a significant
increase in the FlAsH peak, however, the same observations occurred with the control sample
containing buffer instead of glucose. Furthermore, if ATP was responsible for this change in the
FRET signal, then a decrease in the FlAsH peak should have been observed and not an increase.
This increase in the FlAsH peak could be non-specific binding of the dye which could occur with
time. The glucose concentration used in this experiment might have been too low and a higher
concentration can be used to ensure the excess production of ATP in the cells allowing its
detection before its complete consumption by the cells. Therefore, the development of the ATP
biosensor needs further investigation.
In the second set of experiments, compound 1 displayed dose-dependent inhibition with
an IC50 of ~25 µM. Compound 2 did not display any inhibition of ATP synthesis when the
experiments were carried out using MOPS buffer. However, with buffer PA4, some inhibition
occurred and this could be because buffer PA4 has a higher concentration of MgCl2 (5 mM) than
MOPS buffer (2 mM) and it is known that magnesium plays an important role in ATP synthesis
(Ko et al. 1999). The inhibitory effect of compound 2, however, was lower (IC50 > 50 µM) than
compound 1 and the dose-dependency was less noticeable. These results strongly indicate that
the lack of DARQ-sensitivity observed for E. coli at whole cell level is at least in part explained
by the low affinity of DARQs to E. coli ATP synthase. However, at higher concentrations,
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inhibition of ATP synthesis was observed suggesting that E. coli ATP synthase may be used as a
model system to investigate the mechanism of DARQs.
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6. CONCLUSION AND FUTURE PLANS
In this project, there were two sets of experiments carried out highlighting the importance of
$73V\QWKDVHQRWRQO\DVWKHZRUOG¶VVPDOOHVWPRWRUEXWDOVRas a promising drug candidate. In
the first set of experiments, site-specific labeling of ATP synthase in inverted membrane vesicles
of E. coli with the FlAsH moWLI &&3*&& LQFRUSRUDWHGLQWRWKHȖ-subunit of the enzyme and
CFP fused to the a-subunit has shown to be successful. In addition, FRET was successfully
observed from CFP to FlAsH while maintaining the functionality of the constructs. This in vivolike environment was the first step towards the in vivo observation of tKHHQ]\PH¶VDFWLYLW\
However, the presence of a favored resting position for the enzyme was difficult to observe since
it was difficult to distinguish between the quenching caused by ATP and the activity-dependant
change in the FRET signal upon addition of ATP. This could be observed better using singlemolecule FRET experiments. In addition, labeling with site-specific fluorophores in whole
bacterial cells was successful and FRET observation might also be possible. The bacterial cells
survived after around three hours of FlAsH-labeling. This in vivo labeling system could act as a
marker for bacterial metabolism and may also form the basis for a potential genetically-encoded,
FRET-based ATP biosensor. To further investigate this, an experiment will be carried out where
a series of glucose concentrations will be used to find the optimum concentration which would
result in the production of excess ATP thus allowing its detection prior to its complete
consumption by the cells.
In the second set of experiments, it was shown that ATP synthase is a promising drug
target of DARQs. Compound 1 has shown successful dose-dependent inhibition of ATP
synthesis in inverted membrane vesicles of E. coli RA1 strain with an IC50 of approximately 25
µM. As for compound 2, some inhibition occurred but the inhibitory effect was lower compared
to compound 1 with an IC50 of more than 50 µM and the dose-dependency was less obvious. The
low affinity of DARQs to E. coli ATP synthase could be part of the explanation for the lack of
DARQ-sensitivity observed for E. coli at whole cell level. However, the inhibition of ATP
synthesis at higher concentrations suggests that E. coli ATP synthase may be used as a model
system for future single-molecule experiments to investigate the inhibitory mechanism of
DARQs.
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7. TABLE
Table 1. Current first line anti-tuberculosis drugs and their mechanisms of action. (Table
modified from: Rivers and Mancera 2008).

Drug

Mechanism of action

Isoniazid

Prodrug activated by Mycobacterium tuberculosis catalaseperoxidase. Inhibits mycolic synthesis in the cell wall of the
bacteria.

Rifampicin

Inhibits transcriptioQE\LQWHUDFWLQJZLWKWKHȕ-subunit of

(also known as Rifampin)

bacterial RNA polymerase enzyme.

Pyrazinamide

Prodrug converted by mycobacterial pyrazinamidases to active
pyrazinoic acid. Lowers intracellular pH to a level that
inactivates a vital fatty acid synthase.

Ethambutol

Inhibits arabinosyl transferase involved in cell wall biosynthesis.

Streptomycin

Inhibits protein synthesis by binding to the 30S ribosomal
subunit preventing protein chain growth and recognition of
mRNA triplet code.
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8. FIGURES

Figure 1. Structure of bacterial ATP synthase. The bacterial ATP synthase represents the
simplest form of the enzyme. It consists of two protein complexes each acting as a motor: a
transmembrane portion, Fo (a1b2c10-15), and a water soluble portion, F1 Į3ȕ3Ȗįİ In E. coli, the c
ring consists of 10 subunits whereas in other organisms it consists of 10 to 15 subunits.
Mitochondrial ATP synthase has additional subunits in the Fo motor. In all organisms, the Fo
motor is responsible for proton translocation across the membrane, whereas, F1 is responsible for
ATP synthesis/hydrolysis. The enzyme can also be divided into a rotor (F1 Ȗİ-Fo c10-15) and a
stator (F1 Į3ȕ3į- Fo ab2) in which the side stalk, consisting of the į- and b2-subunits, prevents the
rotation of the stator with the rotor.
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Figure 2. Structure of FlAsH-EDT2. Fluorescein arsenical hairpin binder-ethanedithiol
(FlAsH-EDT2) is non-fluorescent by itself but in the presence of a tetracysteine motif
(CCPGCC), the two molecules of EDT are replaced by the four thiol groups of the motif and the
bound FlAsH becomes strongly fluorescent. The excitation and emission peaks of FlAsH-EDT2
are 508 and 528 nm, respectively. (Figure reprinted from: Invitrogen 2010)
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Figure 3. A comparison of the to-scale images of GFP and the tetracysteine-biarsenical
complex. Green fluorescent protein (GFP) is composed of 238 amino acids and has a molecular
weight of 27 kDa while the tetracysteine motif can be as short as 6 amino acids and the
biarsenical-tetracysteine complex has a molecular weight of < 1 kDa. (Figure reprinted from:
Zhang et al. 2002).
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Figure 4. Schematic diagram showing FRET process from CFP to FlAsH. After labeling
ATP synthase with the FlAsH dye, the cyan fluorescent protein (CFP) fused to the a-subunit is
excited using a wavelength of 434 nm. Fluorescence resonance energy transfer (FRET) occurs
from CFP to FlAsH which in turn gets excited emitting fluorescence with a peak at ~528 nm. For
FRET WRRFFXUWKHGRQRU¶VHPLVVLRQ VSHFWUXPPXVWRYHUODSZLWKWKHDFFHSWRU¶VDEVRUSWLRQ
spectrum. In addition, the donor and acceptor must be in close proximity (within 10 nm).
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Figure 5. Structure of TMC207. TMC207 is the lead compound of diarylquinolines (DARQs),
the new class of anti-tuberculosis drugs. TMC207 can inhibit both drug-sensitive and drugresistant M. tuberculosis in vitro and in vivo.
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Figure 6. Schematic diagram showing the structure of inverted membrane vesicles.
Bacterial whole cells are broken using the One Shot Cell Disrupter and cell debris and intact
cells are spun down. The supernatant containing the inverted membrane vesicles is then spun
down and cell pellets are resuspended with buffer. The inverted membrane vesicles produced
from whole bacterial cells have the F1 parts of ATP synthase on the outside of their membranes
whereas the whole cells have their F1 parts on the inside.
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Figure 7. CFP fluorescence detection. The graph shows the fluorescence intensity of the four
constructs ZW&\VȖDECFP and aECFP- &\VȖ and CFP as a control. Excitation wavelength
was set at 434 nm. The two maximum peaks of CFP (~475 and ~502 nm) were present in both
constructs containing CFP fused to the C-terminus of the a-subunit of ATP synthase (aECFP&\VȖDQGDECFP).
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Figure 8. Structure of ACMA and 9-AA. ACMA is a derivative of 9-AA. Both dyes are pH
sensitive and can be used in monitoring proton transport in membrane vesicles.
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Figure 9. Proton transport measurement by fluorescence quenching. Uncharged fluorescent
9-aminoacridine (9-AA) readily crosses the membrane. Upon addition of ATP, ATP hydrolysis
takes place causing protons to be pumped inside the vesicles. 9-AA becomes protonated and
eventually forms dimers which results in the quenching of 9-AA. Upon addition of an uncoupler,
holes are formed in the membranes dissipating the pH gradient and restoring the fluorescence of
9-AA. (Figure modified from: Taiz and Zeiger 2010).
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Figure 10. Proton transport measurement of inverted membrane vesicles before FlAsHlabeling. To confirm the functionality of ATP synthase in all four constructs ZW&\VȖDECFP
and aECFP- &\VȖ , proton transport was monitored by fluorescence quenching of a pH sensitive
dye, ACMA. The membrane vesicles were added to a solution of ACMA in buffer in a cuvette
which was placed in a Varian Cary Eclipse fluorescence spectrophotometer. The excitation and
emission wavelengths were set at 410 and 480 nm, respectively. Reaction was initiated upon
addition of ATP inducing ATP hydrolysis and causing protons to be pumped inside the vesicles
hence quenching the fluorescence of ACMA. Upon addition of SF6847, the uncoupler, holes
were formed in the membranes causing protons to escape and restoring the fluorescence of
ACMA.
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Figure 11. FlAsH-labeling and FRET observation in inverted membrane vesicles of aECFP&\VȖ construct normalized to wt. The graph shows the fluorescence intensity, measured using
an excitation wavelength of 434 nm, of aECFP- &\VȖQRUPDOLzed to wt. Normalization is carried
out by subtracting the results of wt from the results of aECFP- &\VȖ. After two hours of FlAsHlabeling, CFP peak at ~475 nm decreased and FlAsH peak at ~530 nm appeared indicating
successful FlAsH-labeling and FRET occurrence from CFP to FlAsH.
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Figure 12. FlAsH-labeling and FRET observation in inverted membrane vesicles of all four
constructs. (A) aECFP- &\VȖ % ZW & &\VȖ ' DECFP. The graphs show the fluorescence
intensity of the four constructs at 0, 60 and 120 minutes with the excitation wavelength set at 434
nm (specific for CFP). In aECFP- &\VȖ, after two hours of FlAsH-labeling the CFP peak at
~475 nm decreased and the FlAsH peak at ~530 nm appeared indicating successful FlAsHlabeling and FRET occurrence from CFP to FlAsH. This is not seen in the wt and aECFP
constructs since they lacked the FlAsH motif. The FlAsH peak in the &\VȖ construct, which
contained the FlAsH motif, increased by time although this construct did not contain CFP. This
means that FlAsH can be excited with the 434 nm wavelength which is specific for CFP.
Therefore, the increase seen in (A) is not entirely due to FRET but some of it is due to the fact
that FlAsH can be slightly excited at 434 nm.

35

A

C

aECFP- &\VȖ

B

&\VȖ

D

wt

aECFP

Figure 13. FlAsH peak in inverted membrane vesicles of all four constructs. (A) aECFP&\VȖ % ZW & &\VȖ ' DECFP. The graphs show the fluorescence intensity of the four
constructs at 0, 60 and 120 minutes with the excitation wavelength set at 508 nm (specific for
FlAsH). In the aECFP- &\VȖ and &\VȖ constructs, after two hours, the FlAsH peak at ~530 nm
appeared indicating successful FlAsH-labeling. This is not seen in the wt and aECFP constructs
since they lacked the FlAsH motif.
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Figure 14. Proton transport measurement in inverted membrane vesicles after FlAsHlabeling. To confirm the functionality of ATP synthase in all four constructs after two hours of
FlAsH-labeling, proton transport was monitored by fluorescence quenching of ACMA, as
described previously in Figure 10. The graph shows that all four constructs were still active.
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Figure 15. Nucleotide-dependency of FRET signal in aECFP- &\VȖ construct. The graphs
show the FRET signal with the excitation wavelength set at 434 nm before and after the addition
of 20 µL of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides
were added after two hours of FlAsH-labeling. ID/IA was calculated for each case with the donor
peak at 475 nm and the acceptor peak at 528 nm. (A) 20 µL of buffer PA4. ID/IA before and after
addition of buffer = 0.93 (B) ADP: [ID/IA]Before = 0.91, [ID/IA]After = 0.96 (C) AMP-PNP:
[ID/IA]Before = 0.79, [ID/IA]After = 0.77 (D) ATP: [ID/IA]Before = 0.81, [ID/IA]After = 1.10. (E) GTP:
[ID/IA]Before = 0.82, [ID/IA]After = 0.86. The graphs show that ATP causes a significant change in
the FRET signal.
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Figure 16. Nucleotide-dependency of FlAsH signal in aECFP- &\VȖ construct. The graphs
show the FlAsH peak with the excitation wavelength set at 508 nm before and after the addition
of 20 µL of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides
were added after two hours of FlAsH-labeling. (A) 20 µL of buffer PA4 (B) ADP (C) AMP-PNP
(D) ATP (E) GTP. A significant decrease in the FlAsH peak is observed with ATP as opposed to
the buffer and the other nucleotides.
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Figure 17. Nucleotide-dependency of FRET signal in wt construct. The graphs show the
FRET signal with the excitation wavelength set at 434 nm before and after the addition of 20 µL
of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides were added
after two hours of FlAsH-labeling. ID/IA was calculated for each case with the donor peak at 475
nm and the acceptor peak at 528 nm. (A) 20 µL of buffer PA4. Before and after addition of
buffer, ID/IA = 1.07 (B) ADP: [ID/IA]Before = 1.11, [ID/IA]After = 1.22 (C) AMP-PNP: [ID/IA]Before =
0.94, [ID/IA]After = 1.02 (D) ATP: [ID/IA]Before = 1.07, [ID/IA]After = 1.32 (E) GTP: [ID/IA]Before =
0.98, [ID/IA]After = 1.02. The graphs show that ATP causes a change in the FRET signal.
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Figure 18. Nucleotide-dependency of FlAsH signal in wt construct. The graphs show the
FlAsH peak with the excitation wavelength set at 508 nm before and after the addition of 20 µL
of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides were added
after two hours of FlAsH-labeling. (A) 20 µL of buffer PA4 (B) ADP (C) AMP-PNP (D) ATP
(E) GTP.
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Figure 19. Nucleotide-dependency of FRET signal in &\VȖ construct. The graphs show the
FRET signal with the excitation wavelength set at 434 nm before and after the addition of 20 µL
of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides were added
after two hours of FlAsH-labeling. ID/IA was calculated for each case with the donor peak at 475
nm and the acceptor peak at 528 nm. (A) 20 µL of buffer PA4: [ID/IA]Before = 0.73 [ID/IA]After =
0.72 (B) ADP: [ID/IA]Before = 0.72, [ID/IA]After = 0.76 (C) AMP-PNP: [ID/IA]Before = 0.79,
[ID/IA]After = 0.81 (D) ATP: [ID/IA]Before = 0.69, [ID/IA]After = 0.93 (E) GTP: [ID/IA]Before = 0.57,
[ID/IA]After = 0.60. The graphs show that ATP causes a change in the FRET signal.
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Figure 20. Nucleotide-dependency of FlAsH signal in &\VȖ construct. The graphs show the
FlAsH peak with the excitation wavelength set at 434 nm before and after the addition of 20 µL
of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides were added
after two hours of FlAsH-labeling. (A) 20 µL of buffer PA4 (B) ADP (C) AMP-PNP (D) ATP
(E) GTP. A significant decrease in the FlAsH peak is observed with ATP.
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Figure 21. Nucleotide-dependency of FRET signal in aECFP construct. The graphs show the
FRET signal with the excitation wavelength set at 434 nm before and after the addition of 20 µL
of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides were added
after two hours of FlAsH-labeling. ID/IA was calculated for each case with the donor peak at 475
nm and the acceptor peak at 528 nm. (A) 20 µL of buffer PA4: [ID/IA]Before = 1.35 [ID/IA]After =
1.36 (B) ADP: [ID/IA]Before = 1.40, [ID/IA]After = 1.37 (C) AMP-PNP: [ID/IA]Before = 1.47,
[ID/IA]After = 1.43 (D) ATP: [ID/IA]Before = 1.29, [ID/IA]After = 1.38 (E) GTP: [ID/IA]Before = 1.29,
[ID/IA]After = 1.30. The graphs show that ATP causes a slight change in the FRET signal.
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Figure 22. Nucleotide-dependency of FlAsH signal in aECFP construct. The graphs show the
FlAsH peak with the excitation wavelength set at 434 nm before and after the addition of 20 µL
of 100 mM of each nucleotide to achieve a final concentration of 2 mM. Nucleotides were added
after two hours of FlAsH-labeling. (A) 20 µL of buffer PA4 (B) ADP (C) AMP-PNP (D) ATP
(E) GTP.
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Figure 23. Effect of addition of 2 mM nucleotides on CFP. The graphs show the CFP signal
(excitation at 434 nm) before and after the addition of 20 µL of 100 mM of each nucleotide to
achieve a final concentration of 2 mM. (A) 20 µL of buffer PA4, ~ 19% quenching (B) ADP,
~ 25% quenching (C) AMP-PNP, ~ 25% quenching (D) ATP, ~ 29% quenching (E) GTP, ~ 18%
quenching. The graphs show that ATP causes a greater degree of CFP quenching than the other
nucleotides.
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Figure 24. Effect of addition of 10 mM nucleotides on CFP. The graphs show the CFP signal
(excitation at 434 nm) before and after the addition of 100 µL of 100 mM of each nucleotide to
achieve a final concentration of 10 mM. (A) 100 µL of buffer PA4 showing ~25% quenching (B)
ADP showing ~34% quenching (C) ATP showing ~50% quenching. The graphs show that ATP
has a greater quenching effect on CFP compared to ADP and the buffer.
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Figure 25. Effect of FlAsH-EDT2 on cell survival. 50 µL of FlAsH-EDT2 was added to a
solution containing whole cells and 50 µL of buffer PA4 to another solution containing the same
volume of whole cells. After ~3 hours, ~3 µL of each sample was streaked on a plate and plates
were left overnight in an incubator at 37 °C. (A) Whole cells without FlAsH-labeling (B) Whole
cells with FlAsH-labeling. The picture shows no significant difference in the number of cells
between the two samples indicating that FlAsH did not affect cell survival.
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Figure 26. FlAsH-labeling and FRET observation in whole cells. The graph shows the
fluorescence intensity of whole cells at 434 and 508 nm. (A) aECFP at 434 nm. (B) aECFP&\VȖ at 434 nm. After two hours of FlAsH-labeling, CFP peak at ~475 nm decreased and
FlAsH peak at ~530 nm appeared indicating successful FlAsH-labeling and the possibility of
FRET occurrence from CFP to FlAsH. (C) aECFP at 508 nm. (D) aECFP- &\VȖDWQP. The
FlAsH peak significantly increases with time indicating successful FlAsH-labeling.
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Figure 27. Effect of addition of ATP on FRET signal in whole cells. After two hours of
FlAsH-labeling, 20 µL of 100 mM ATP was added to achieve a final concentration of 2 mM (A)
aECFP at 434 nm: [ID/IA]Before = 1.34, [ID/IA]After = 1.35 (B) aECFP- &\VȖ at 434 nm: [ID/IA]Before
= 1.02, [ID/IA]After = 0.99 (C) aECFP at 508 nm (D) aECFP- &\VȖDWQP. The graphs show
no significant change in the FRET signal or the FlAsH peak upon addition of ATP.
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Figure 28. Effect of incubation with glucose on FRET signal in whole cells. After two hours
of FlAsH-labeling, 25 µL of 1 M glucose was added to one sample to achieve a final
concentration of 25 mM and 25 µL of buffer PA4 was added to another sample as a control. Both
samples were incubated at 37°C and the signal was measured after 30, 70 and 220 min. (A)
Before and after the addition of glucose using an excitation wavelength of 434 nm (B) Before
and after the addition of buffer PA4 using an excitation wavelength of 434 nm. In spite of the
increase in the FlAsH peak by time, the graphs show no difference between the addition of
glucose and buffer PA4.
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Figure 29. GFP fluorescence detection. The graph shows the fluorescence intensity of three
different batches of inverted membrane vesicles of E. coli RA1 strain harboring the plasmid
pSD166 which codes for E. coli ATP synthase with EGFP fused to the C-terminus of the asubunit of the enzyme. Excitation wavelength was set at 480 nm. The graph shows the maximum
peak of GFP (at ~506 nm) present in all three batches.
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Figure 30. Reactions of the ATP synthesis assay. ATP synthase synthesizes ATP from ADP
and inorganic phosphate (Pi) in the presence of NADH. The produced ATP is transformed into
glucose-6-phosphate in the presence of hexokinase and glucose in the reaction sample. NADPH
is produced upon the addition of glucose-6-phosphate dehydrogenase. The production of
NADPH can be monitored at a wavelength of 340 nm.

53

G6PD

Figure 31. ATP synthesis in inverted membrane vesicles of E. coli RA1 strain. The graph
represents raw data of one experiment of ATP synthesis using batch 1 and different
concentrations of compound 1. Samples were incubated for 20 minutes at 37°C in the presence
of NADH, ADP and Pi. The produced ATP is converted to glucose-6-phosphate in the presence
of glucose and hexokinase in the reaction sample. Production of NADPH was initiated by the
addition of glucose-6-phosphate dehydrogenase (G6PD) and absorbance of NADPH was
measured at 340 nm.
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Figure 32. Effect of compound 1 on ATP synthesis in inverted membrane vesicles of E. coli
RA1 strain using MOPS buffer. The graph represents the mean values of three independent
experiments with standard deviation. Inhibition of compound 1 was normalized against DMSO
while DCCD was normalized against ethanol. Compound 1 displayed dose-dependent inhibition
with an IC50 of ~25 µM.
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Figure 33. Effect of compound 2 on ATP synthesis in inverted membrane vesicles of E. coli
RA1 strain using MOPS buffer. The graph represents the mean values of three independent
experiments. Inhibition of compound 2 was normalized against DMSO while DCCD was
normalized against ethanol. Compound 2 did not display dose-dependent inhibition using MOPS
buffer.
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Figure 34. Effect of compound 2 on ATP synthesis in inverted membrane vesicles of E. coli
RA1 strain using buffer PA4. The graph represents the mean values of three independent
experiments. Inhibition of compound 2 was normalized against DMSO while DCCD was
normalized against ethanol. Compound 2 displayed some dose-dependent inhibition using buffer
PA4.
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Figure 35. Schematic diagram showing how ATP might bind to FlAsH. The diagram shows
that one or both of the arsenic atoms of FlAsH might be able to bind to ATP through the oxygen
atoms of its phosphate groups.
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